NCT06036368View on ClinicalTrials.gov

Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

June 30, 2024

Conditions
Parkinson's DiseaseEssential Tremor
Interventions
DEVICE

Peroneal electrical transcutaneous neuromodulation (peroneal eTNM®)

This is a non-invasive intervention, which utilizes direct trancutaneous, electrical stimulation of the peroneal nerve

Trial Locations (1)

70200

Cerebrovaskulární poradna s.r.o., Ostrava

All Listed Sponsors
lead

Stimvia s.r.o.

INDUSTRY

NCT06036368 - Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor | Biotech Hunter | Biotech Hunter